Page last updated: 2024-08-25

rosiglitazone and Leukemia, Lymphocytic, T Cell

rosiglitazone has been researched along with Leukemia, Lymphocytic, T Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, H; Hong, T; Wang, H; Wei, R; Yang, J; Yu, F	1

Other Studies

1 other study(ies) available for rosiglitazone and Leukemia, Lymphocytic, T Cell

Article	Year
Anti-proliferative effect of rosiglitazone in the human T-lymphocyte leukaemia cell line Jurkat cells. Cell biology international, 2018, Volume: 42, Issue:5 Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Humans; Jurkat Cells; Leukemia, T-Cell; Metformin; PPAR gamma; Receptor, IGF Type 1; Receptor, Insulin; Receptors, Somatomedin; RNA, Messenger; Rosiglitazone; Thiazolidinediones	2018

Article

Year

Anti-proliferative effect of rosiglitazone in the human T-lymphocyte leukaemia cell line Jurkat cells.

Cell biology international, 2018, Volume: 42, Issue:5

Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Humans; Jurkat Cells; Leukemia, T-Cell; Metformin; PPAR gamma; Receptor, IGF Type 1; Receptor, Insulin; Receptors, Somatomedin; RNA, Messenger; Rosiglitazone; Thiazolidinediones

2018